# To Explore the Feasibility of Dynamic Changes of TCR Diversity in Peripheral Blood in Monitoring Recurrence and Evaluating Prognosis of Epithelial Ovarian Cancer

> **NCT06315270** · — · NOT_YET_RECRUITING · sponsor: **The First Hospital of Jilin University** · enrollment: 100 (estimated)

## Conditions studied

- Epithelial Ovarian Cancer
- Stage III Ovarian Cancer
- Stage IV Ovarian Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06315270
- **Lead sponsor:** The First Hospital of Jilin University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-03-20
- **Primary completion:** 2029-03-20
- **Final completion:** 2029-03-20
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06315270

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06315270, "To Explore the Feasibility of Dynamic Changes of TCR Diversity in Peripheral Blood in Monitoring Recurrence and Evaluating Prognosis of Epithelial Ovarian Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06315270. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*